QUANTIFICATION OF FREE AND CONJUGATED BISPHENOL A IN HUMAN FETAL LIVER TISSUE

2011 ◽  
Vol 2011 (1) ◽  
Author(s):  
Muna Nahar ◽  
Chunyang Liao ◽  
Kurunthachalam Kannan ◽  
Laura Rozek ◽  
Dana Dolinoy
Keyword(s):  
Bisphenol A ◽  
Liver Tissue ◽  
Fetal Liver ◽  
Human Fetal Liver

Human hepatic stimulator substance: A product of gene expression of human fetal liver tissue

Hepatology ◽  
1993 ◽  
Vol 17 (2) ◽  
pp. 225-229 ◽  
Author(s):  
Fuchu He ◽  
Chutse Wu ◽  
Qiang Tu ◽  
Guichun Xing
Keyword(s):  
Gene Expression ◽  
Liver Tissue ◽  
Fetal Liver ◽  
Human Fetal Liver ◽  
Hepatic Stimulator Substance

Mesenchymal stromal cells isolated from human fetal liver release soluble factors with a potential role in liver tissue repair

2019 ◽  
Vol 105 ◽  
pp. 14-26 ◽  
Author(s):  
Cinzia Maria Chinnici ◽  
Giada Pietrosi ◽  
Gioacchin Iannolo ◽  
Giandomenico Amico ◽  
Nicola Cuscino ◽  
...  
Keyword(s):  
Mesenchymal Stromal Cells ◽  
Stromal Cells ◽  
Liver Tissue ◽  
Tissue Repair ◽  
Potential Role ◽  
Fetal Liver ◽  
Soluble Factors ◽  
Human Fetal Liver

Long-term cultures of human fetal liver cells: a three-dimensional experimental model for monitoring liver tissue development

1998 ◽  
Vol 28 (3) ◽  
pp. 480-490 ◽  
Author(s):  
Massimo Sargiacomo ◽  
Paolo Onori ◽  
Elena Bravo ◽  
Antonio Franchitto ◽  
Alfredo Cantafora ◽  
...  
Keyword(s):  
Experimental Model ◽  
Liver Tissue ◽  
Fetal Liver ◽  
Three Dimensional ◽  
Liver Cells ◽  
Tissue Development ◽  
Human Fetal Liver ◽  
Fetal Liver Cells ◽  
Human Fetal Liver Cells

Use of human fetal liver cells for treatment of patients with lower limb peripheral artery disease

2014 ◽  
Vol 2 (1) ◽  
pp. 10-13
Author(s):  
R. Salyutin ◽  
D. Dombrowski ◽  
M. Komarov ◽  
N. Sokolov ◽  
S. Palyanitsya ◽  
...  
Keyword(s):  
Progenitor Cells ◽  
Lower Limb ◽  
Fetal Liver ◽  
Life Quality ◽  
Liver Cells ◽  
Surgical Reconstruction ◽  
Clinical Effects ◽  
Doppler Flowmetry ◽  
Human Fetal Liver ◽  
Fetal Liver Cells

In the group of patients (n = 21, mean age 54 ± 5.8 years) with chronic lower limb ischemia stage IIB who were non-liable for reconstructiverestoration surgery, we have established positive clinical effects of local transplantation of human fetal liver progenitor cells. Complex examination following 1, 3, 6 and 12 months after transplantation included duplex scanning of limb arteries, x-ray contrast arteriography and laser Doppler flowmetry as well as measuring pain-free walking and evaluating life quality based on individual questionnaire data.Owing to the transplant “Cryopreserved human fetal liver progenitor cells” the patients demonstrated stable increase of life quality index and pain-free walking as well as improvement of general health allowing assign them to the group of patients with lower ischemia stage,  quicker social rehabilitation and lesser risk of disabling surgery (р < 0.05). Also, there were observations of improved microcirculation in the ischemic extremities owing to activation of endothelium-independent mechanisms of vasodilatation, reduced myotonus and neurotonus of the pre-capillaries and improved endothelium-dependent influence on the microhaemodynamic and, hence, an increased reserve capillary blood flow (p < 0.05).Analysis of the obtained results indicates prospects and effectiveness of using fetal liver cells transplantation in the patients who are not liable for surgical reconstruction of the vascular bed.

Sign in / Sign up

Export Citation Format

Share Document